Cargando…

Core Signs and Symptoms in Children with Autism Spectrum Disorder Improved after Starting Risperidone and Aripiprazole in Combination with Standard Supportive Therapies: A Large, Single-Center, Retrospective Case Series

Background: There are a number of medications prescribed to address comorbid challenging behaviors in children with autism spectrum disorder (ASD), including risperidone and aripiprazole. This retrospective case series reports the use of these drugs in children aged 2 to 13 years. Methodology: A tot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsayouf, Hamza A., Talo, Haitham, Biddappa, Marisa L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139358/ https://www.ncbi.nlm.nih.gov/pubmed/35625005 http://dx.doi.org/10.3390/brainsci12050618

Ejemplares similares

Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study
por: Alsayouf, Hamza A., et al.
Publicado: (2021)

Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series
por: Alsayouf, Hamza A, et al.
Publicado: (2020)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania
por: Rezayat, Amir Akhavan, et al.
Publicado: (2014)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia
por: Pandey, Ravi S., et al.
Publicado: (2017)

Treatment of Misophonia with Risperidone in a Patient with Autism Spectrum Disorder
por: Pan, Eric J., et al.
Publicado: (2022)

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
por: Racki, Valentino, et al.
Publicado: (2021)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)

Risperidone for children and adolescents with autism spectrum disorder: a systematic review
por: Maneeton, Narong, et al.
Publicado: (2018)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole
por: Osuna-Luque, Jaime, et al.
Publicado: (2018)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Gene expression in blood is associated with risperidone response in children with autism spectrum disorders
por: Lit, Lisa, et al.
Publicado: (2011)

The Effects of Risperidone on Cognition in People With Autism Spectrum Disorder: A Systematic Review
por: Hutchinson, Jhenelle, et al.
Publicado: (2023)

Effects of Risperidone on Core Symptoms of Autistic Disorder Based on Childhood Autism Rating Scale: An Open Label Study
por: Ghaeli, Padideh, et al.
Publicado: (2014)

When to start aripiprazole therapy in patients with bipolar mania
por: Sayyaparaju, Kiran Kumar, et al.
Publicado: (2014)

Duchenne Muscular Dystrophy Successfully Treated with Aripiprazole in a Patient with Autism Spectrum Disorder Symptoms Including Irritability
por: Noda, Seiya, et al.
Publicado: (2021)

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors
por: Vanwong, Natchaya, et al.
Publicado: (2020)

Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder
por: Kloosterboer, Sanne Maartje, et al.
Publicado: (2020)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole
por: Remmerie, Bart, et al.
Publicado: (2016)

Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
por: Maneeton, Narong, et al.
Publicado: (2018)

Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects
por: Vanwong, Natchaya, et al.
Publicado: (2017)

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
por: Hongkaew, Yaowaluck, et al.
Publicado: (2021)

Early Motor Signs in Autism Spectrum Disorder
por: Posar, Annio, et al.
Publicado: (2022)

Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole
por: Remmerie, Bart, et al.
Publicado: (2016)

The Difference of Fasting Blood Sugar of Male Patients with Schizophrenia Treated with Flexible Dose between Aripiprazole and Risperidone in Medan, Indonesia
por: Marni, Trisna, et al.
Publicado: (2019)

Adverse Effects of Risperidone in Children with Autism Spectrum Disorders in a Naturalistic Clinical Setting at Siriraj Hospital, Thailand
por: Boon-yasidhi, Vitharon, et al.
Publicado: (2014)

Comparison of Aripiprazole and Risperidone effectiveness in treating obsessive‐compulsive disorder in patients with bipolar disorder: Double‐blind, randomized clinical trial
por: Khorshidian, Faezeh, et al.
Publicado: (2023)

Alternative starting regimen with aripiprazole long-acting treatments, a case report
por: Huete Naval, M., et al.
Publicado: (2022)

Aripiprazole lai two-injection start in a 16 year-old with Schizophrenia
por: Marpepa, B., et al.
Publicado: (2022)

Core-Symptom-Defined Cortical Gyrification Differences in Autism Spectrum Disorder
por: Ning, Mingmin, et al.
Publicado: (2021)

Drug repurposing candidates to treat core symptoms in autism spectrum disorder
por: Koch, Elise, et al.
Publicado: (2022)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Canitano, Roberto, et al.
Publicado: (2008)

Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine
por: Kasahara, Satoshi, et al.
Publicado: (2022)

Comparison of risperidone and aripiprazole in the treatment of preschool children with disruptive behavior disorder and attention deficit-hyperactivity disorder: A randomized clinical trial
por: Safavi, Parvin, et al.
Publicado: (2016)

Aripiprazole in the treatment of Huntington’s disease: a case series
por: Ciammola, Andrea, et al.
Publicado: (2009)

Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder
por: Bangerter, Abi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l4ph0nh6nnl432nff41am7ouko